Clinical Trials Browser

Phase 1 × Has results × Solid Tumor × Clear all

NCT03770494 2025-11-04

A Study of LY3405105 in Participants With Advanced Cancer

Phase 1 Terminated

54 enrolled 26 charts

Other solid neoplasm

Solid Tumor

NCT03994211 2024-10-26

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

Phase 1 Completed

25 enrolled 33 charts

Other solid neoplasm

Solid Tumor

NCT02718911 2023-10-16

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Phase 1 Completed

72 enrolled 23 charts

Other solid neoplasm

Solid Tumor

NCT02278250 2023-03-16

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Phase 1 Completed

97 enrolled 77 charts

Other solid neoplasm

Solid Tumor

NCT03894540 2022-09-13

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Phase 1 Terminated

22 enrolled 27 charts

Other solid neoplasm

Solid Tumor

NCT04035473 2022-04-13

A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel

Phase 1 Completed

42 enrolled 21 charts

Other solid neoplasm

Solid Tumor

NCT01004861 2022-01-04

Safety Study of PLX108-01 in Patients With Solid Tumors

Phase 1 Completed

132 enrolled 28 charts

Other solid neoplasm

Solid Tumor

NCT03752177 2021-10-22

A Study of LY3415244 in Participants With Advanced Solid Tumors

Phase 1 Terminated

12 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT03961100 2020-09-07

A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.

Phase 1 Completed

31 enrolled 14 charts

Other solid neoplasm

Solid Tumor

NCT03042910 2019-12-17

A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors

Phase 1 Completed

38 enrolled 24 charts

Other solid neoplasm

Solid Tumor

NCT02737072 2019-08-12

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

Phase 1 Terminated

9 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT02490475 2017-05-17

A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors

Phase 1 Completed

19 enrolled 25 charts

Other solid neoplasm

Solid Tumor

NCT00467779 2016-08-26

Study of Cobimetinib in Participants With Solid Tumors

Phase 1 Completed

119 enrolled 63 charts

Other solid neoplasm

Solid Tumor

NCT01327313 2016-05-13

A Study of EMD525797 in Solid Tumor Patients in Japan

Phase 1 Completed

27 enrolled 34 charts

Other solid neoplasm

Solid Tumor

NCT02494596 2015-11-10

A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors

Phase 1 Completed

19 enrolled 16 charts

Other solid neoplasm

Solid Tumor

NCT01463982 2015-04-23

Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Phase 1 Completed

21 enrolled 10 charts

Other solid neoplasm

Solid Tumor